Placental HtrA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages 403-411

  Li, Ying ^a   Puryer, Michelle ^a   Lin, Eliane ^a   Hale, Kathryn ^a   Salamonsen, Lois A ^a   Manuelpillai, Ursula ^a   Tong, Stephen ^a   Chan, Weng ^a   Wallace, Euan M ^a   Nie, Guiying ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH TEMPERATURE REQUIREMENT FACTOR A3; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OXYGEN TENSION; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; CELL LINE; CELLS, CULTURED; CHORIONIC VILLI; DOWN-REGULATION; FEMALE; GIANT CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; ORGAN CULTURE TECHNIQUES; OXYGEN CONSUMPTION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RISK; SERINE ENDOPEPTIDASES; TROPHOBLASTS;

MACACA MULATTA;

EID: 79951694182     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1405     Document Type: Article

References (39)

1. Walker JJ 2000 Pre-eclampsia. Lancet 356:1260-1265
2. Roberts JM, Cooper DW 2001 Pathogenesis and genetics of preeclampsia. Lancet 357:53-56
3. Lyell DJ, Lambert-Messerlian GM, Giudice LC 2003 Prenatal screening, epidemiology, diagnosis, and management of preeclampsia. Clin Lab Med 23:413-442 (Pubitemid 36791315)
4. Digiacinto D, Graves M 2009 Uterine artery Doppler and its value in predicting preeclampsia. J Diagnostic Medical Sonography 25:73-77
5. Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, Hyde C, Khan KS 2009 Are tests for predicting preeclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 88:758-765
6. Redman CW, Sargent IL 2005 Latest advances in understanding preeclampsia. Science 308:1592-1594 (Pubitemid 40807500)
7. Wang A, Rana S, Karumanchi SA 2009 Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 24:147-158
8. Roberts JM, Hubel CA 2009 The two stage model of preeclampsia: variations on the theme. Placenta 30(Suppl A):S32-S37
9. Pijnenborg R, Vercruysse L, Hanssens M 2006 The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27:939-958 (Pubitemid 44204033)
10. James JL, Stone PR, Chamley LW 2006 The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update 12:137-144 (Pubitemid 43231447)
11. Nie GY, Hampton A, Li Y, Findlay JK, Salamonsen LA 2003 Identification and cloning of two isoforms of human HtrA3, characterisation of its genomic structure and the comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J 371:39-48 (Pubitemid 36458077)
12. Nie GY, Li Y, Minoura H, Batten L, Ooi GT, Findlay JK, Salamonsen LA 2003 A novel serine protease of the mammalian HtrA family is up-regulated in mouse uterus coinciding with placentation. Mol Hum Reprod 9:279-290 (Pubitemid 36748831)
13. Nie G, Li Y, Hale K, Okada H, Manuelpillai U, Wallace EM, Salamonsen LA 2006 Serine protease HtrA3 is closely associated with human placental development and is detectable in pregnancy serum. Biol Reprod 74:366-374 (Pubitemid 43122288)
14. Nie G, Li Y, He H, Findlay JK, Salamonsen LA 2006 HtrA3, a serine protease possessing an IGF-binding domain, is selectively expressed at the maternal-fetal interface during placentation in the mouse. Placenta 27:491-501
15. Bowden M, Li Y, Liu YX, Findlay J, Salamonsen L, Nie G 2008 HtrA3 expression in non-pregnant rhesus monkey ovary and endometrium, and at the maternal-fetal interface during early pregnancy. Reprod Biol Endocrinol 6:22
16. Vande Walle L, Lamkanfi M, Vandenabeele P 2008 The mitochondrial serine protease HtrA2//Omi: an overview. Cell Death Differ 15:453-460 (Pubitemid 351267296)
17. Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M, Richards P, Jones SA, Shridhar V, Clausen T, Ehrmann M 2005 Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci USA 102:6021-6026 (Pubitemid 40594248)
18. Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, Teismann P, Abuin A, Grau E, Geppert M, Livi GP, Creasy CL, Martin A, Hargreaves I, Heales SJ, Okada H, Brandner S, Schulz JB, Mak T, Downward J 2004 Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 24:9848-9862 (Pubitemid 39458812)
19. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K 2006 A variant of the HtrA1 gene increases susceptibility to age-related macular degeneration. Science 314:992-993 (Pubitemid 44749944)
20. Chien J, Campioni M, Shridhar V, Baldi A 2009 HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets 9:451-468
21. Ligam P, Manuelpillai U, Wallace EM, Walker D 2005 Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for a role of the kynurenine pathway in pregnancy. Placenta 26:498-504 (Pubitemid 40796578)
22. North RA, Ferrier C, Long D, Townend K, Kincaid-Smith P 1994 Uterine artery doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol 83:378-386 (Pubitemid 24067806)
23. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG 2001 Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583 (Pubitemid 32448325)
24. Krauss T, Pauer HU, Augustin HG 2004 Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 23:101-111 (Pubitemid 38445556)
25. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA 2004 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683 (Pubitemid 38364626)
26. Wathén KA, Tuutti E, Stenman UH, Alfthan H, Halmesmäki E, Finne P, Ylikorkala O, Vuorela P 2006 Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 91:180-184 (Pubitemid 43069135)
27. Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, Uzan S, Rondeau E 2004 Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 50:1702-1703 (Pubitemid 39121252)
28. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA 2006 Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992-1005 (Pubitemid 44343543)
29. Robinson CJ, Johnson DD 2007 Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol 197:174.e1-174.e175
30. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS 2006 A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 27:13-17 (Pubitemid 43129084)
31. Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, Gibor Y 2008 Placental protein 13 as an early marker for preeclampsia: a prospective longitudinal study. BJOG 115:1465-1472
32. Than NG, Romero R, Hillermann R, Cozzi V, Nie G, Huppertz B 2008 Prediction of preeclampsia - a workshop report. Placenta 29(Suppl A):S83-S85
33. Baumann MU, Bersinger NA, Surbek DV 2007 Serum markers for predicting pre-eclampsia. Mol Aspects Med 28:227-244 (Pubitemid 46843194)
34. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y 2008 Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 14:855-862
35. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R 2008 Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453:1117-1121
36. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658 (Pubitemid 36278583)
37. Tocharus J, Tsuchiya A, Kajikawa M, Ueta Y, Oka C, Kawaichi M 2004 Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-β signaling. Dev Growth Differ 46:257-274 (Pubitemid 38943090)
38. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M 2004 HtrA1 serine protease inhibits signaling mediated by TGFβ family proteins. Development 131:1041-1053 (Pubitemid 38380458)
39. Launay S, Maubert E, Lebeurrier N, Tennstaedt A, Campioni M, Docagne F, Gabriel C, Dauphinot L, Potier MC, Ehrmann M, Baldi A, Vivien D 2008 HtrA1-dependent proteolysis of TGFβ controls both neuronal maturation and developmental survival. Cell Death Differ 15:1408-1416